Tufts CSDD FACULTY
Kenneth I Kaitin, PhD
Professor and Director
Kenneth Kaitin is a Professor at Tufts University School of Medicine and the Director of the Tufts Center for the Study of Drug Development. He is also an Advisory Professor at Shanghai Medical College at Fudan University, and he serves on the faculty of the European Center for Pharmaceutical Medicine at the University of Basel. An internationally recognized expert in drug development science and policy, Dr. Kaitin writes, speaks, and teaches on global trends in pharmaceutical development and regulation, and he has provided public testimony before the U.S. Congress. A former President of the Drug Information Association, Dr. Kaitin is currently Editor-in-Chief of Expert Review of Clinical Pharmacology, and he is a consultant to the U.S. Department of Defense on bioterror countermeasures. In 2011, he received the Dr. Louis M. Sherwood Award, granted by the Academy of Pharmaceutical Physicians and Investigators. Dr. Kaitin serves on several public and private company boards of directors. He received his BS from Cornell University and MS and PhD in pharmacology from the University of Rochester.
Joseph A. DiMasi, PhD
Director of Economic Analysis and Research Associate Professor
Dr. DiMasi's area of expertise is in R&D efficiency, approval success rates, development and regulatory approval time metrics, impact of regulatory policies, economics of innovation in the pharmaceutical and biotechnology industries. Dr. DiMasi's research interests include the R&D cost of new drug development, clinical success and phase attrition rates, development and regulatory approval times, the role that pharmacoeconomic evaluations have played in the R&D process, pricing and profitability in the pharmaceutical industry, innovation incentives for pharmaceutical R&D, and changes in the structure and performance of the pharmaceutical and biotechnology industries. His current research initiatives include:
R&D Costs for New Drug Development – New estimates of the R&D cost per approved new drug will be developed for drugs as a whole, by phase of development, and molecule type. The costs of failures and time costs will be considered.
Cancer Drug Development Trends – Analyses of approval success rates and phase transition rates for first and follow-on indications for oncology drugs by molecule type, as well as analysis of reasons for failure.
Kenneth A. Getz, MBA
Director of Sponsored Research and Research Associate Professor
Mr. Getz Directs the Sponsored Research Program at Tufts CSDD. He is an internationally recognized expert on pharmaceutical R&D management, protocol design, outsourcing, data management, investigative site management and patient engagement. A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Mr. Getz has published extensively in peer-review journals, books and in the trade press. He holds a number of board appointments in the private and public sectors. He received his MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree from Brandeis University. Ken is also the chairman of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise and the founder of CenterWatch, a leading publisher in the clinical trials industry.
Mr. Getz' current research initiatives include:
Evaluating the ROI of Patient Engagement -- Principal Investigator
Assessing the Magnitude and Cost of Unused Protocol Data -- Principal Investigator
Mapping the eClinical Landscape and Benchmarking Data Management Practices -- Principal Investigator
Monitoring the Global Investigative Site Landscape-- Principal Investigator
Benchmarking Patient Recruitment and Retention Practices -- Principal Investigator
Assessing the Accuracy and Completeness of Adverse Event Report Data -- Principal Investigator
Richard I. Shader, MD
Medical Consultant and Professor Emeritus
Dr. Shader is Professor Emeritus of Molecular Physiology and Pharmacology and Professor Emeritus of Psychiatry at the Tufts University School of Medicine in Boston, Massachusetts. He is a former chairman of the Department of Pharmacology and Experimental Therapeutics and of the Department of Psychiatry. Dr. Shader until 2010, served as Program Director for the graduate studies in the Program in Pharmacology & Experimental Therapeutics at the Sackler School of Biomedical Sciences. He is also a Senior Research Fellow and Medical Consultant at the Tufts Center for the Study of Drug Development. In addition to being a former MERIT Investigator of the National Institutes of Health (NIH), Dr. Shader was also a member of the National Advisory Mental Health Council for the National Institute of Mental Health (NIMH). He has served on an NIMH study section and is a frequent ad hoc reviewer. He was a member of the Scientific Advisory Board for the NIMH Hypericum Trial and of the Advisory Board for the NIMH Research Units in Pediatric Psychopharmacology. At present, he is on the overall Data Safety Monitoring Board (DSMB) for the NIH Center for Complementary and Alternative Medicine as well as on the DSMB for its Silymarin trials. Dr. Shader is past president of the American College of Neuropsychopharmacology, the American Board of Psychiatry and Neurology, and the American Association of Chairmen of Departments of Psychiatry. He is a former Director and member of the Executive Committee of the American Board of Emergency Medicine and now serves as a Senior Director. Dr. Shader was an individual winner of the American Psychiatric Association’s Seymour Vestermark Award for Psychiatric Education, and received it a second time with colleagues from the American College of Neuropsychopharmacology. He has been a member of the Scientific Advisory Board of the Alzheimer’s Foundation and the Association for Aging Research. During the academic year 1990-1991, he was the Kaiser Fellow at the Center for Advanced Studies in the Behavioral Sciences in Stanford, California. A 1956 graduate of Harvard College, Dr. Shader received his medical degree from the New York University School of Medicine in 1960. He received his psychiatric training at the Massachusetts Mental Health Center at Harvard Medical School and the NIMH in Bethesda, Maryland. He also graduated from the Boston Psychoanalytic Institute. He is Editor-in-Chief of the Journal of Clinical Psychopharmacology. In addition, he is the author or co-author of over 600 scientific publications and the author, editor, or co-editor of 18 scientific books and monographs. Among the latter is the very popular Manual of Psychiatric Therapeutics first published by Little Brown and Company (now Lippincott-Williams & Wilkins).
Tufts CSDD research STAFF
Mary Jo Lamberti, PhD
Associate Director of Sponsored Research, Research Assistant Professor
Dr. Mary Jo Lamberti manages multi-sponsored and grant funded research projects at Tufts CSDD. She has extensive experience conducting market research on pharmaceutical industry practices and trends affecting contract research organizations and investigative sites. She has been a speaker at conferences and has published articles in trade and peer-reviewed journals. Prior to joining Tufts CSDD, Dr. Lamberti was director of market research at CenterWatch. She has also worked on federally funded research studies in science education reform. Dr. Lamberti holds a BA from Wellesley College and a PhD in psychology from Boston University.
Stella Stergiopoulos, MS-MPH
Assistant Director of Statistics and Analytics, Research Instructor
Ms. Stella Stergiopoulos manages multi-sponsored and grant funded research projects at Tufts CSDD. She has experience conducting research on pharmaceutical industry practices and trends affecting pharmacovigilance, non-clinical drug development, pharmaceutical outsourcing practices, cycle time metrics, resource management, and protocol design. She has also been a speaker at conferences and has published articles in peer-reviewed and trade journals. Prior to joining Tufts CSDD, Ms. Stergiopoulos was a research associate at The Brattle Group and a researcher at Massachusetts General Hospital. She holds a BA from Brandeis University, and an MS and MPH from Tufts University.
Michael Wilkinson, BA
Senior Research Analyst
Michael Wilkinson works for the Sponsored Research program within the Tufts CSDD focusing on database creation and development, grant research, and pharmaceutical company and product research. Mr. Wilkinson received a BA from the University of Massachusetts Lowell in the field of Sociology focusing on quantitative research, while obtaining minors in both legal studies and business. In the past, he has been employed by the U.S. Department of the Interior: Office of Surface Mining Reclamation and Enforcement, helping to support and coordinate their VISTA program and the sociology department at UML where he assisted by performing initial literature reviews for faculty research and presenting material to students.
Yaritza Peña, bs
Yaritza Peña is a research analyst in the sponsored research group where she focuses on drug development trends, outsourcing and patient recruitment and retention. Ms. Peña received a BS from Bentley University in Economics with a concentration in Information Design and Corporate Communications. She has experience conducting research on sustainable agricultural practices in the Caribbean and on the effects of the drivers of economic growth and development on real GDP and economic growth in South American countries.
Zachary Smith, ma
Zachary completed his BS at Florida Southern College, and received his MA from Brandeis University. He has worked as a research assistant at a variety of labs including the Etter Lab at the University of Massachusetts, and the Evolutionary Psychology Lab at Harvard University.
Tufts CSDD administrative staff
Sundé Daniels, MBA
Director of Administration and Development, Administrative Manager
Miss Sundé W. Daniels works with the Tufts CSDD Director in the design and implementation of all CSDD activities. This includes: operations and logistics, financials (budgets, fundraising, sponsorship), educational programs (continuing education, career | professional development workshops), and identification of opportunities for collaboration with internal and external partners. Sundé’s strong background in the pharmaceutical industry, academia, and business fuels her passion for biopharmaceutical innovation. Her career has afforded her to work with companies and institutions such as Pfizer (formerly Wyeth), Boston University Boston Medical Center and Harvard University. Most recently she served as Department Administrator for two different departments at Harvard University.
Grant & Program Administrator
Ms. Evelyn Chan is responsible for planning, managing, and forecasting the budget and financial activities for the Tufts CSDD. Ms. Chan handles registrants’ payments for courses, Tufts CSDD publication purchases, and financial inquiries.
Rachel Stanton, BFA
Special Projects Coordinator, Design | Staff Assistant
Ms. Rachel Stanton, an alumna of Massachusetts College of Art and Design (BFA, Illustration), provides administrative, marketing, and design project support for Tufts CSDD. Her primary duties include providing assistance to the Administrative Manager in maintaining Tufts CSDD’s Sponsorship Program, as well as providing critical support for Center meetings, events, and office management. She is the in-house designer for Tufts CSDD.
GERALDIN BATISTA, MA
Marketing & Communications Coordinator
Ms. Geraldin Batista received her MA from Suffolk University in Communications with an Integrated Marketing Communication concentration. As the Marketing & Communications Coordinator for Tufts CSDD she is responsible for the design implementation of marketing strategies/campaigns and providing advanced level support in promoting effective communications across and outside of the center. She assists in the development of print materials, messaging, design and layout of publications, coordination of publicity materials, advertising and public relations for events. In addition, she supports creating, monitoring and updating website, social media posts and monitors activity and triages or refers media inquiries to appropriate party.